佐力药业(300181.SZ)拟推2024年限制性股票激励计划

智通财经10-27

智通财经APP讯，佐力药业(300181.SZ)发布2024年限制性股票激励计划(草案)，拟向激励对象授予限制性股票不超过660.5万股，涉及的标的股票种类为人民币A股普通股股票，约占激励计划公告日公司总股本的0.94%。其中，首次授予限制性股票585.5万股，预留75万股。授予价格为8.07元/股。此次激励计划拟首次授予的激励对象总人数为112人，激励计划有效期自限制性股票首次授予之日起至激励...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2478590801?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-10-27 18:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2478590801","market":"us","top_or_hot":-1,"title":"佐力药业(300181.SZ)拟推2024年限制性股票激励计划","media":"智通财经","content":"<div>\n<p>智通财经APP讯，佐力药业(300181.SZ)发布2024年限制性股票激励计划(草案)，拟向激励对象授予限制性股票不超过660.5万股，涉及的标的股票种类为人民币A股普通股股票，约占激励计划公告日公司总股本的0.94%。其中，首次授予限制性股票585.5万股，预留75万股。授予价格为8.07元/股。此次激励计划拟首次授予的激励对象总人数为112人，激励计划有效期自限制性股票首次授予之日起至激励...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1200846.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>佐力药业(300181.SZ)拟推2024年限制性股票激励计划</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n佐力药业(300181.SZ)拟推2024年限制性股票激励计划\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-27 18:54 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1200846.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，佐力药业(300181.SZ)发布2024年限制性股票激励计划(草案)，拟向激励对象授予限制性股票不超过660.5万股，涉及的标的股票种类为人民币A股普通股股票，约占激励计划公告日公司总股本的0.94%。其中，首次授予限制性股票585.5万股，预留75万股。授予价格为8.07元/股。此次激励计划拟首次授予的激励对象总人数为112人，激励计划有效期自限制性股票首次授予之日起至激励...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1200846.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1200846.html","article_id":"2478590801","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2478590801","pubTimestamp":1730026454,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，佐力药业(300181.SZ)发布2024年限制性股票激励计划(草案)，拟向激励对象授予限制性股票不超过660.5万股，涉及的标的股票种类为人民币A股普通股股票，约占激励计划公告日公司总股本的0.94%。其中，首次授予限制性股票585.5万股，预留75万股。授予价格为8.07元/股。此次激励计划拟首次授予的激励对象总人数为112人，激励计划有效期自限制性股票首次授予之日起至激励对象获授的限制性股票全部归属或作废失效之日止，最长不超过60个月。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"300181":"佐力药业","BK0239":"医药制造","BK0042":"基因检测","BK0077":"质押式回购"},"translate_title":"Zuoli Pharmaceutical (300181. SZ) plans to launch a restricted stock incentive plan in 2024","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300181":1},"content_text":"智通财经APP讯，佐力药业(300181.SZ)发布2024年限制性股票激励计划(草案)，拟向激励对象授予限制性股票不超过660.5万股，涉及的标的股票种类为人民币A股普通股股票，约占激励计划公告日公司总股本的0.94%。其中，首次授予限制性股票585.5万股，预留75万股。授予价格为8.07元/股。此次激励计划拟首次授予的激励对象总人数为112人，激励计划有效期自限制性股票首次授予之日起至激励对象获授的限制性股票全部归属或作废失效之日止，最长不超过60个月。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2478590801"}